VEE Vaccine for Venezuelan Equine Encephalomyelitis (VEE Trial)

"Enrollees for this encephalomyelitis trial must be aged between 18 and 65, possess a VEE virus PRNT80 below 1:10., have submitted an IND Vaccine Request Form, signed the necessary informed consent documents and authorizations, undergone recent medical history checks (including medication use), physical examinations and laboratory tests within one year of their first vaccine dose, presented previous chest radiography results or electrocardiograms to investigators who will then medically clear them for participation. In addition, female participants are required to undertake serum pregnancy tests before administration with negative results expected; they also need to agree not become pregnant in the three months"

"Eligible participants of this medical trial must fall within the age range of 18-65. For those outside that boundary, there are 49 clinical trials for minors and 92 studies targeting geriatric patients."

"It is affirmed on clinicaltrials.gov that this particular study has ceased to enroll participants, having been posted originally on May 30th 2018 and last updated February 10th 2021. At the present moment, 131 other trials are actively recruiting patients for their research programs."

"Our evaluation of the VEE Vaccine safety has been assessed as 2, given that it is currently in a Phase 2 trial with evidence assuring its security but lacking proof of efficacy."